Legislation would enable CROs to claim R&D tax credit
Proposed legislation would enable contract research organizations (CRO) to claim an R&D tax credit – increasing incentive to conduct clinical trials in the US.
Archives for April 5, 2017
India cracks down on oxytocin makers to curb misuse in labour wards
India has told state regulators to inspect API sites making oxytocin in an effort to prevent the hormone being used to speed up childbirth without medical justification.
Shire success will support polysialic acid drug delivery platform, says Xenetic
Xenetic Biosciences says success for Shire’s haemophilia A candidate SHP656 will validate its PolyXen drug delivery technology platform and could net the firm up to $100m.
Medichem's solid dosage form plant approved by US FDA
A Combino Pharm dosage form plant in Malta has passed a US FDA inspection according to parent Medichem, which says it is now poised to expand its US business.
Strike ends at Pfizer plant after firm lets new staff join pension plan
Industrial action at a Pfizer Ireland Ltd plant in Ringaskiddy, County Cork has ended after the firm agreed to let 35 new staff to join the company pension scheme.
Catalent: five-fold increase in capacity to support growing demand
Catalent Pharma Solutions has increased its controlled-temperature storage capabilities as it continues to invest in its clinical supply business.
Novel in vitro approach bypasses in vivo bioequivalence studies
Diteba has developed a novel in vitro approach that allows sponsors to avoid in vivo bioequivalence studies in accordance with a recently released FDA draft guidance.